Literature DB >> 17192349

Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome.

Noriko Satoh1, Akira Shimatsu, Kazuhiko Kotani, Naoki Sakane, Kazunori Yamada, Takayoshi Suganami, Hideshi Kuzuya, Yoshihiro Ogawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17192349     DOI： 10.2337/dc06-1179

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  37 in total

Review 1.  DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity.

Authors:  Yonggang Ma; Merry L Lindsey; Ganesh V Halade
Journal:  Expert Opin Drug Discov       Date:  2012-06-24       Impact factor: 6.098

2.  Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles.

Authors:  C B Dias; N Amigo; L G Wood; X Correig; M L Garg
Journal:  Eur J Clin Nutr       Date:  2017-05-10       Impact factor: 4.016

3.  Overview of omega-3 Fatty Acid therapies.

Authors:  J Chris Bradberry; Daniel E Hilleman
Journal:  P T       Date:  2013-11

Review 4.  Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis.

Authors:  Melissa Y Wei; Terry A Jacobson
Journal:  Curr Atheroscler Rep       Date:  2011-12       Impact factor: 5.113

5.  Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study.

Authors:  Ramin Farzaneh-Far; William S Harris; Sachin Garg; Beeya Na; Mary A Whooley
Journal:  Atherosclerosis       Date:  2008-12-14       Impact factor: 5.162

Review 6.  Do statins reduce events in patients with metabolic syndrome?

Authors:  Sarah P Towne; Eddie Thara
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

Review 7.  Omega-3 fatty acids: how can they be used in secondary prevention?

Authors:  Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Curr Atheroscler Rep       Date:  2008-12       Impact factor: 5.113

8.  Inflammation in response to n3 fatty acids in a porcine obesity model.

Authors:  Richard J Faris; Rebecca L Boddicker; Jennifer Walker-Daniels; Jenny Li; Douglas E Jones; Michael E Spurlock
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

9.  Using high-dose omega-3 fatty acid supplements to lower triglyceride levels in 10- to 19-year-olds.

Authors:  Sarah D de Ferranti; Carly E Milliren; Erica R Denhoff; Sarah K Steltz; Elif Seda Selamet Tierney; Henry A Feldman; Stavroula K Osganian
Journal:  Clin Pediatr (Phila)       Date:  2014-05       Impact factor: 1.168

Review 10.  A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021.

Authors:  Tahreem Iqbal; Michael Miller
Journal:  Curr Cardiol Rep       Date:  2021-07-11       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.